Endocrinologie : ce qui a changé en 2024 [Endocrinology : what's new in 2024]
Gespeichert in:
| Titel: | Endocrinologie : ce qui a changé en 2024 [Endocrinology : what's new in 2024] |
|---|---|
| Autoren: | Ameti, A., Cruchon, K., Giordani, I., Papadakis, G., Sykiotis, G.P. |
| Quelle: | Revue medicale suisse, vol. 21, no. 902, pp. 126-130 |
| Verlagsinformationen: | 2025. |
| Publikationsjahr: | 2025 |
| Schlagwörter: | Humans, Endocrinology/trends, Endocrinology/methods, Endocrine System Diseases/therapy, Adrenal Hyperplasia, Congenital/diagnosis, Adrenal Hyperplasia, Congenital/therapy, Adrenal Hyperplasia, Congenital/drug therapy, Adult, Child, Endocrine Surgical Procedures/methods, Endocrine Surgical Procedures/trends, Acromegaly/therapy, Acromegaly/drug therapy, Acromegaly/diagnosis |
| Beschreibung: | In this article, we look at a selection of recent developments in various areas of endocrinology. We focus on advances in endocrine pharmacotherapy and endocrine surgery, addressing several areas: a) the thyroid safety of Glucagon-Like Peptide-1 (GLP1) analogues; b) the efficacy of adrenal surgery for mild autonomous cortisol secretion; c) crinecerfont in the management of congenital adrenal hyperplasia in adults and children; d) paltusotin as a novel oral therapy for acromegaly and e) TransCon PTH (palopegteriparatide) as a novel therapy for chronic hypoparathyroidism. |
| Publikationsart: | Review |
| Dateibeschreibung: | application/pdf |
| Sprache: | French |
| Zugangs-URL: | https://serval.unil.ch/notice/serval:BIB_EF5C5669B961 http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_EF5C5669B9612 https://serval.unil.ch/resource/serval:BIB_EF5C5669B961.P001/REF.pdf |
| Rights: | CC BY NC ND |
| Dokumentencode: | edsair.od......1900..8812e1157e66e3d570881a29b73f6310 |
| Datenbank: | OpenAIRE |
Nájsť tento článok vo Web of Science | Abstract: | In this article, we look at a selection of recent developments in various areas of endocrinology. We focus on advances in endocrine pharmacotherapy and endocrine surgery, addressing several areas: a) the thyroid safety of Glucagon-Like Peptide-1 (GLP1) analogues; b) the efficacy of adrenal surgery for mild autonomous cortisol secretion; c) crinecerfont in the management of congenital adrenal hyperplasia in adults and children; d) paltusotin as a novel oral therapy for acromegaly and e) TransCon PTH (palopegteriparatide) as a novel therapy for chronic hypoparathyroidism. |
|---|